Literature DB >> 18842058

Lynamicins A-E, chlorinated bisindole pyrrole antibiotics from a novel marine actinomycete.

Katherine A McArthur1, Scott S Mitchell, Ginger Tsueng, Arnold Rheingold, Donald J White, Jennifer Grodberg, Kin S Lam, Barbara C M Potts.   

Abstract

A series of chlorinated bisindole pyrroles, lynamicins A-E (1-5), was discovered from a novel marine actinomycete, NPS12745, which was isolated from a marine sediment collected off the coast of San Diego, California. Close to full length 16S rRNA sequence analysis indicated that NPS12745 is a novel strain of a recently described marine actinomycete with the proposed genus name Marinispora. The antimicrobial spectrum of these compounds was evaluated against a panel of 11 pathogens, which demonstrated that these substances possess broad-spectrum activity against both Gram-positive and Gram-negative organisms. Significantly, compounds 1-5 were active against drug-resistant pathogens such as methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococcus faecium.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18842058     DOI: 10.1021/np800286d

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  28 in total

1.  Chrysophaentins A-H, antibacterial bisdiarylbutene macrocycles that inhibit the bacterial cell division protein FtsZ.

Authors:  Alberto Plaza; Jessica L Keffer; Giuseppe Bifulco; John R Lloyd; Carole A Bewley
Journal:  J Am Chem Soc       Date:  2010-07-07       Impact factor: 15.419

Review 2.  Comparative mass spectrometry-based metabolomics strategies for the investigation of microbial secondary metabolites.

Authors:  Brett C Covington; John A McLean; Brian O Bachmann
Journal:  Nat Prod Rep       Date:  2017-01-04       Impact factor: 13.423

Review 3.  Antitumor compounds from marine actinomycetes.

Authors:  Carlos Olano; Carmen Méndez; José A Salas
Journal:  Mar Drugs       Date:  2009-06-11       Impact factor: 5.118

4.  Activity of the streptogramin antibiotic etamycin against methicillin-resistant Staphylococcus aureus.

Authors:  Nina M Haste; Varahenage R Perera; Katherine N Maloney; Dan N Tran; Paul Jensen; William Fenical; Victor Nizet; Mary E Hensler
Journal:  J Antibiot (Tokyo)       Date:  2010-03-26       Impact factor: 2.649

Review 5.  Novel anti-infective compounds from marine bacteria.

Authors:  Hafizur Rahman; Brian Austin; Wilfrid J Mitchell; Peter C Morris; Derek J Jamieson; David R Adams; Andrew Mearns Spragg; Michael Schweizer
Journal:  Mar Drugs       Date:  2010-03-05       Impact factor: 5.118

Review 6.  Immense essence of excellence: marine microbial bioactive compounds.

Authors:  Ira Bhatnagar; Se-Kwon Kim
Journal:  Mar Drugs       Date:  2010-10-15       Impact factor: 5.118

Review 7.  Antimicrobial compounds from marine actinomycetes.

Authors:  Cong Wang; Yuanyu Lu; Shugeng Cao
Journal:  Arch Pharm Res       Date:  2020-07-20       Impact factor: 4.946

8.  Further studies on the application of vinylogous amides and β-halovinylaldehydes to the regiospecific synthesis of unsymmetrical, polyfunctionalized 2,3,4- and 1,2,3,4- substituted pyrroles.

Authors:  John T Gupton; Alex Shimozono; Evan Crawford; Joe Ortolani; Evan Clark; Matt Mahoney; Campbell Heese; Jeffrey Noble; Carlos Perez Mandry; Rene Kanters; Raymond N Dominey; Emma W Goldman; James A Sikorski; Daniel C Fisher
Journal:  Tetrahedron       Date:  2018-04-07       Impact factor: 2.457

9.  Isolation of a small molecule with anti-MRSA activity from a mangrove symbiont Streptomyces sp. PVRK-1 and its biomedical studies in Zebrafish embryos.

Authors:  Rajaretinam Rajesh Kannan; Appadurai Muthamil Iniyan; Vincent Samuel Gnana Prakash
Journal:  Asian Pac J Trop Biomed       Date:  2011-10

Review 10.  Cross-coupling reactions towards the synthesis of natural products.

Authors:  Shaheera Tabassum; Ameer Fawad Zahoor; Sajjad Ahmad; Razia Noreen; Samreen Gul Khan; Hamad Ahmad
Journal:  Mol Divers       Date:  2021-02-20       Impact factor: 2.943

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.